Free Disclosure Statement - District Court of Delaware - Delaware

Case 1:08-cv-00455-JJF Document 9 Filed 08/13/2008 Page 1 of 1
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
X
CEPHALON, INC. and CIMA LABS, INC.,
Plaintiffs. Q case Ne. es-ev-00455 (UNA)
v.
_ BARR PI-IARMACEUTICALS, INC., and
BARR LABORATORIES, INC., ;
Defendants.
X
DEFENDANTS’ RULE 7.1 DISCLOSURE
Defendants Barr Laboratories, Inc. and Barr Pharmaceuticals, Inc. make the following
disclosure pursuant to Federal Rule of Civil Procedure 7.l:
Defendant Barr Laboratories, Inc. is a wholly~oWned subsidiary of Defendant Barr
Pharmaceuticals, Inc. Barr Pharmaceuticals, Inc. is publicly traded on the New York Stock
Exchange under the ticker symbol BRL. To the best of our knowledge as of the date hereof} no
publicly-held corporation or parent corporation currently owns 10% or more of Barr
Pharmaceuticals? stock. However, Barr Pharmaceuticals recently entered into an agreement with
Teva Pharmaceutical Industries Ltd. whereby Teva has agreed to acquire Barr Pharmaceuticals.
It is expected that this agreement will be finalized sometime in the fourth quarter of 2008.
Respectfully submitted,
Dated: August i2, 2008 By:
.l C. 1pS, Jr. (#1l0)
PHILLI , GOLDMAN &; SPENCE, P.A.
1200 North Broom Street
Wilmington, DE 19806
(302) 655-4200 (telephone)
(302) 655-4210 (facsimile)
[email protected]

Case 1:08-cv-00455-JJF

Document 9

Filed 08/13/2008

Page 1 of 1